Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Gastroenterology

Gastrointestinal Diseases and Disorders

California

Duarte : City of Hope

PHII-66 NCI#7028: A Phase II Study of BAY 43-9006 for Patients with Imatinib-and Sunitinib Resistant Gastrointestinal Stromal Tumor

Florida

Port Orange : Accord Clinical Research, LLC

Prevention of Recurrence of Diverticulitis

Michigan

Kalamazoo : Borgess Research Institute

A study to prevent the reoccurrence of diverticulitis.

Minnesota

Rochester : Research Site

120GS201 - A study of BIIB021, an oral HSP90 inhibitor, in patients with GIST refractory to, or intolerant of, imatinib and sunitinib.

New York

New York : Research Site

120GS201 - A study of BIIB021, an oral HSP90 inhibitor, in patients with GIST refractory to, or intolerant of, imatinib and sunitinib.

Tennessee

Nashville : Research Site

120GS201 - A study of BIIB021, an oral HSP90 inhibitor, in patients with GIST refractory to, or intolerant of, imatinib and sunitinib.

Texas

San Antonio : Clinical Trials of Texas, Inc.

The purpose of this study is to determine whether SPD476 is effective in reducing recurrence of diverticulitis.